单位(元)国泰中证生物医药ETF(512290)资产负债表 |
报告期 |
2024/6/30 |
2023/12/31 |
2023/6/30 |
2022/12/31 |
资产 |
银行存款 |
22,445,105 |
15,254,560 |
8,179,919 |
18,980,095 |
结算备付金 |
1,210,529 |
1,981,230 |
2,231,429 |
5,619,340 |
存出保证金 |
349,834 |
406,485 |
1,215,911 |
1,103,703 |
交易性金融资产 |
3,584,962,309 |
4,661,060,297 |
5,558,104,704 |
3,937,280,343 |
其中:股票投资 |
3,584,962,309 |
4,661,060,297 |
5,558,104,704 |
3,937,280,343 |
基金投资 |
- |
- |
- |
- |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
310,940 |
2,170,207 |
8,996,296 |
1,547,172 |
应收利息 |
- |
- |
- |
- |
应收股利 |
23,668 |
- |
298,188 |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
41,569 |
109,081 |
159,920 |
236,902 |
资产总计 |
3,609,343,953 |
4,680,981,861 |
5,579,186,367 |
3,964,767,554 |
负债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
77,936 |
- |
4,908,514 |
- |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,525,873 |
2,016,375 |
2,271,964 |
1,750,424 |
应付托管费 |
305,175 |
403,275 |
454,393 |
350,085 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
4,923 |
10,000 |
18,766 |
20,404 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
1,671,454 |
4,666,156 |
2,960,986 |
9,412,136 |
负债合计 |
3,585,361 |
7,095,807 |
10,614,623 |
11,533,050 |
所有者权益 |
实收基金 |
4,235,820,694 |
4,091,820,694 |
5,036,820,694 |
3,264,820,694 |
未分配利润 |
-630,062,102 |
582,065,360 |
531,751,050 |
688,413,811 |
所有者权益合计 |
3,605,758,592 |
4,673,886,054 |
5,568,571,744 |
3,953,234,505 |
负债和所有者权益总计 |
3,609,343,953 |
4,680,981,861 |
5,579,186,367 |
3,964,767,554 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。